Life sciences supplier scaling manufacturing and financial operations globally
Antylia Scientific supplies mission-critical products to biotech and pharmaceutical manufacturers—from molecular controls to lab instrumentation. The company is in the middle of an ERP modernization push (Workday + Blackline) paired with aggressive standardization across finance, manufacturing, and supply chain. Hiring velocity is accelerating across finance, support, and product, suggesting a shift from product-led growth toward operational maturity and global scale.
Notable leadership hires: Information Technology Director, Talent Director, IT Director
Antylia Scientific manufactures and distributes products for drug discovery, vaccine development, and diagnostics—serving research labs, bioprocessing facilities, and contract manufacturers worldwide. The company operates across bioanalytical instrumentation (GC/MS, HPLC, LC-MS), LIMS platforms, and molecular control panels. With over 1,000 employees and a 70-year history, Antylia is now executing a significant operational modernization: ERP system replacement, global cost accounting standardization, supplier consolidation, and financial close automation. The product mix and compliance requirements (FDA, ISO 13485, GMP/OSHA) anchor the company in heavily regulated, capital-intensive workflows.
Core systems include Workday (finance/HR), Salesforce (CRM), Blackline (reconciliation), and SAS/Alteryx (analytics). Lab instruments: GC/MS, HPLC, LC-MS. Legacy: AS/400 (being replaced as part of ERP modernization roadmap).
ERP modernization, global cost accounting standardization, supplier consolidation, manufacturing of molecular control panels, and financial close automation via Blackline. Also executing monthly close transformation and variance reporting framework standardization.
Antylia Scientific's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.